Alcon stock: Mizuho cuts target for Alcon stock to USD 80 from USD 85

Published on 10/23/2026 at 15:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are scheduled for November 10, 2026. Alcon stock costs EUR 62.51 on October 23, 2026, down 0.33 percent versus the Xetra close.

Analyst target and reporting date

Mizuho cut its Alcon target from USD 85.00 to USD 80.00 on October 13, 2026.
Alcon is scheduled to report third-quarter results on November 10, 2026.
Alcon stock costs EUR 62.51 at Lang & Schwarz on October 23, 2026 at 3:15 p.m. CEST, 0.33 percent below the Xetra close of October 22, 2026.
Alcon's price-to-earnings ratio was 54.33 and its market capitalization was USD 34.1 billion as of October 22, 2026.

Photorealistic wide panoramic view of a modern ophthalmic surgery operating room. Surgical microscope centered, sterile metallic instruments arranged on blue drape, scrub-suited surgical team in background, cold overhead surgical lighting — Alcon CH0432492467: Augenchirurgie OP Saal mit Mikroskop, sterilen Werkzeugen und einem Operationsteam, Illustration mit AI erstellt.

Alcon stock remains under an analyst reset after Markets Insider reported on October 13, 2026 that Mizuho cut its price target from USD 85.00 to USD 80.00 while retaining an Outperform rating. The revised target lies 13.26 percent above the USD 70.63 NYSE price dated October 22, 2026. At Lang & Schwarz, Alcon was trading at EUR 62.51 on October 23, 2026 at 3:15 p.m. CEST, down 0.33 percent versus the Xetra close of October 22, 2026 at EUR 62.72.

Results date adds a near-term marker

Alcon's next earnings date is November 10, 2026, according to MarketBeat. The company last reported second-quarter revenue of USD 2.82 billion for the period ended June 30, 2026. The next report will therefore give investors a fresh test of demand across Alcon's Surgical and Vision Care businesses.

Stock stays inside its yearly range

Alcon's NYSE price was USD 70.63 on October 22, 2026 at 4:00 p.m. ET. Its USD 61.84 to USD 87.64 52-week range puts the price 14.22 percent above the low and 19.41 percent below the high. Trading volume was 2,207,898 shares on that date.

Valuation remains a key counterweight

Alcon had a price-to-earnings ratio of 54.33 and a market capitalization of USD 34.1 billion as of October 22, 2026. The valuation sits above Stryker's ratio of 31.82 but below Becton, Dickinson and Company's 60.37, while Alcon's market value is smaller than both peers.

Comparison with peers

Alcon: down 0.33 percent versus the Xetra close, price-to-earnings ratio 54.33, market capitalization USD 34.1 billion.

Stryker (NYSE, USD): up 3.19 percent, price-to-earnings ratio 31.82, market capitalization USD 117.8 billion.

Becton, Dickinson and Company (NYSE, USD): up 3.13 percent, price-to-earnings ratio 60.37, market capitalization USD 54.6 billion.

Alcon stock and the next report

The combination of a lower Mizuho target and the November 10 reporting date leaves the next quarterly update as the clearest dated test for the valuation. On the NYSE, the stock last traded at USD 70.63 on October 22, 2026 at 4:00 p.m. ET. At Lang & Schwarz, the stock was trading at EUR 62.51 on October 23, 2026 at 3:15 p.m. CEST, 0.33 percent below the Xetra close of October 22, 2026 at EUR 62.72. The further course of trading is shown by the continuously updated real-time quote of Alcon stock.